Navigation Links
Minority patients prefer optical colonoscopy for colorectal cancer screening

The clinical importance of colorectal cancer screening is well established, however the majority of eligible people do not undergo screening tests. It is important to identify which tests may encourage individuals to be screened in order to help increase the survival rate of the disease. Individuals of racial/ethnic minorities strongly prefer and better tolerate optical colonoscopy (OC) versus white patients who prefer computed tomographic (CT) colonography for the evaluation of the colon, according to a new study published in Clinical Gastroenterology and Hepatology. Additionally, patients who had a prior history of polyps preferred undergoing OC, most likely since they were aware of their increased risk of polyps which would necessitate removal using colonoscopy.

We were somewhat surprised at the results of our study as we had assumed that racial/ethnic minorities would have preferred CT colonography as the less invasive screening test, said Edmund J. Bini, MD, MPH, of the VA New York Harbor Healthcare System and lead investigator of the study. These findings have important clinical implications for the development of programs that will encourage racial and ethnic minorities in the U.S. to be screened for colorectal cancer.

The study found that if recommended by their physicians, significantly more study participants would be willing to undergo OC versus those who would undergo CT colonography. Overall, patients in the study felt OC was more painful than CT colonography, however they experienced more bloating and embarrassment during CT colonography than during OC.

Black patients were the most satisfied with OC as opposed to white participants who were the least satisfied during this procedure. White patients experienced more abdominal pain, discomfort and bloating during OC. Patients who identified their race/ethnicity as other experienced the greatest embarrassment and anxiety scores.

During the CT colonography, white patients experienced the least severity of abdominal pain while Hispanic participants experienced the greatest pain. Black and Hispanic patients felt significantly more embarrassed during CT colonography than did white patients or participants from other racial/ethnic minorities. White participants were significantly more satisfied with CT colonography than other study participants.

The study included 272 participants from diverse racial/ethnic backgrounds including non-Hispanic whites, non-Hispanic blacks, Hispanic individuals and those who self-identified as other. All participants completed both OC and CT colonography. The most common reason participants who were white or who designated their race/ethnicity as other were undergoing colonoscopy was screening. In participants who were black, the most common indication for colonoscopy was a positive fecal occult blood test (FOBT) and in patients who were Hispanic, the most common reasons were hematochezia (blood in the stool) or iron deficiency anemia.

Guidelines from multiple agencies and professional societies, including the AGA Institute, underscore the importance of colorectal cancer screening for all individuals 50 years of age and older (younger for certain groups known to be at higher risk). The U.S. Preventive Services Task Force, the U.S. Multi-Specialty Task Force and others have published recommendations for screening for colorectal cancer, the second-leading cause of cancer deaths in the United States. Currently, recommended screening tests include colonoscopy, flexible sigmoidoscopy, barium enema and fecal occult blood tests.

In September, the AGA Institute issued standards for performance of virtual, or CT, colonography. The AGA Institute will hold a course of CT Colonography on March 7 8, 2008, in Washington, DC. To learn more about AGA Institute initiatives on CTC, please visit the AGA Web site at


Contact: Aimee Frank
American Gastroenterological Association

Related medicine news :

1. Help of Minority Leaders Needed to Curb Polio: Ramadoss
2. Telephone Outreach Boost CRC Screening In Urban Minority
3. Triple Negative Breast Cancers Seem to Affect the Young, Minority
4. Minority Women in LA County Have Higher Rates of Chronic Disease Than Whites
5. One in Three Heart Attack Patients Have No Chest Pains
6. Amphetamines Help Recovery of Stroke Patients
7. Painkillers Do Not Shorten Dying Patients Lives
8. Patients With Filariasis More Prone To HIV Infection
9. Glivec - New Hope For CMC Patients
10. HIV infected patients can travel safely abroad
11. New vaccine helps allergy and asthma patients
Post Your Comments:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology: